The Possible Effects of Roflumilast on Obesity Related Disorders

NCT04800172 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

66

Enrollment

OTHER

Sponsor class

Conditions

Obesity
PreDiabetes

Interventions

DRUG: Roflumilast
DRUG: placebo

Sponsor

Tanta University